US FDA expands approval for J&J's drug for rare blood disorder

Reports

2

Domains carrying it

2

First reported

25 August 2026

Latest report

25 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 25 August 2026US FDA expands approval for J&J's drug for rare blood disorderreuters.com
2. 25 August 2026U.S. FDA expands approval for J&J's drug for rare blood disorderbnnbloomberg.ca

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• US FDA approves Takeda, Protagonist's drug for rare blood cancer3 reports · 3 domains · 1 September 2026
• FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia11 reports · 10 domains · 2 September 2026
• FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune ...11 reports · 11 domains · 1 September 2026
• FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder14 reports · 12 domains · 1 September 2026
• FDA Approves Gene Therapy for Glycogen Storage Disease Type 1a6 reports · 6 domains · 22 August 2026
• FDA Allows First Gene Therapy Clinical Trial for Ultra-Rare Pediatric Neurodegenerative Disease2 reports · 2 domains · 4 September 2026

◆ Share

◆ Evidence

2 reports · 2 domains

• U.S. FDA expands approval for J&J's drug for rare blood disorderbnnbloomberg.ca · 25 August 2026
• US FDA expands approval for J&J's drug for rare blood disorderreuters.com · 25 August 2026